Free Trial

Harbor Capital Advisors Inc. Boosts Stock Position in U.S. Physical Therapy, Inc. $USPH

U.S. Physical Therapy logo with Medical background

Key Points

  • Harbor Capital Advisors Inc. increased its stake in U.S. Physical Therapy, Inc. by 30% during the second quarter, owning approximately 0.15% of the company valued at $1.73 million.
  • U.S. Physical Therapy reported $0.81 earnings per share for the quarter, surpassing expectations, with a revenue of $197.34 million, marking an 18% increase year-over-year.
  • Several analysts have upgraded their ratings and price targets for U.S. Physical Therapy, with Barrington Research raising its price objective from $98 to $103, while JPMorgan set a target of $110.
  • MarketBeat previews the top five stocks to own by October 1st.

Harbor Capital Advisors Inc. grew its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 30.0% in the second quarter, according to its most recent filing with the SEC. The fund owned 22,079 shares of the company's stock after acquiring an additional 5,101 shares during the quarter. Harbor Capital Advisors Inc. owned about 0.15% of U.S. Physical Therapy worth $1,727,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Nuveen LLC purchased a new stake in U.S. Physical Therapy during the first quarter valued at $8,702,000. Bahl & Gaynor Inc. increased its holdings in shares of U.S. Physical Therapy by 32.6% in the 1st quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company's stock worth $24,964,000 after buying an additional 84,878 shares during the last quarter. Nuveen Asset Management LLC raised its position in shares of U.S. Physical Therapy by 95.9% during the 4th quarter. Nuveen Asset Management LLC now owns 120,893 shares of the company's stock valued at $10,724,000 after buying an additional 59,190 shares in the last quarter. Woodline Partners LP lifted its holdings in shares of U.S. Physical Therapy by 228.0% in the 1st quarter. Woodline Partners LP now owns 82,419 shares of the company's stock valued at $5,964,000 after acquiring an additional 57,293 shares during the last quarter. Finally, Jane Street Group LLC grew its position in U.S. Physical Therapy by 249.3% in the first quarter. Jane Street Group LLC now owns 49,309 shares of the company's stock worth $3,568,000 after acquiring an additional 35,191 shares in the last quarter.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,792 shares of the company's stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $86.57, for a total value of $155,133.44. Following the completion of the sale, the chief operating officer owned 22,246 shares of the company's stock, valued at approximately $1,925,836.22. This represents a 7.45% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Carey P. Hendrickson sold 698 shares of the stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $86.11, for a total transaction of $60,104.78. Following the transaction, the chief financial officer owned 27,808 shares in the company, valued at approximately $2,394,546.88. This represents a 2.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,853 shares of company stock worth $581,406. 2.00% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

USPH has been the topic of a number of recent research reports. JPMorgan Chase & Co. initiated coverage on U.S. Physical Therapy in a research report on Thursday. They set an "overweight" rating and a $110.00 price objective on the stock. Wall Street Zen downgraded U.S. Physical Therapy from a "buy" rating to a "hold" rating in a research report on Sunday. Zacks Research upgraded U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. Finally, Barrington Research lifted their price objective on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a research note on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Read Our Latest Research Report on U.S. Physical Therapy

U.S. Physical Therapy Trading Up 1.6%

USPH stock traded up $1.26 during midday trading on Monday, reaching $79.74. The company's stock had a trading volume of 114,786 shares, compared to its average volume of 118,892. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $101.19. The firm has a market capitalization of $1.21 billion, a price-to-earnings ratio of 34.82, a PEG ratio of 3.93 and a beta of 1.47. The stock has a fifty day simple moving average of $80.33 and a two-hundred day simple moving average of $76.39. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.10. The firm had revenue of $197.34 million for the quarter, compared to analysts' expectations of $190.24 million. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The business's revenue for the quarter was up 18.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.73 earnings per share. On average, equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 12th. Shareholders of record on Friday, August 22nd were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 dividend on an annualized basis and a yield of 2.3%. U.S. Physical Therapy's dividend payout ratio (DPR) is 78.60%.

U.S. Physical Therapy Profile

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Articles

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.